|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/353 | (2013.01) |
| C07K 16/22 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K 31/4745 | (2013.01) | ||
| C07K 16/46 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/282 | (2006.01) | ||
| C07K 16/28 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 39/3955 | (2013.01) | ||
| A61K 39/39558 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K2039/507 | (2013.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/31 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K 16/22 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/282 | (2013.01) | ||
| A61K 31/337 | (2013.01) | ||
| A61K 33/24 | (2013.01) | ||
| A61K 33/243 | (2019.01) |
| (11) | Number of the document | 3353204 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16849686.7 |
| Date of filing the European patent application | 2016-09-23 | |
| (97) | Date of publication of the European application | 2018-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/053316 |
| Date | 2016-09-23 |
| (87) | Number | WO 2017/053705 |
| Date | 2017-03-30 |
| (30) | Number | Date | Country code |
| 201562222505 P | 2015-09-23 | US |
| (72) |
DUPONT, Jakob , US
PARMAR, Hema , US
STAGG, Robert Joseph , US
|
| (73) |
Mereo BioPharma 5, Inc. ,
800 W El Camino Real
Suite 180, Mountain View, CA 94040,
US
|
| (54) | BI-SPECIFIC ANTI-VEGF/DLL4 ANTIBODY FOR USE IN TREATING PLATINUM-RESISTANT OVARIAN CANCER |
| BI-SPECIFIC ANTI-VEGF/DLL4 ANTIBODY FOR USE IN TREATING PLATINUM-RESISTANT OVARIAN CANCER |